Forbes January 4, 2024
Joshua Cohen

A push to lift Medicare’s prohibition on coverage of weight loss drugs is picking up steam in Congress. The history of the Treat and Reduce Obesity Act, which would allow coverage of obesity medications, goes back a decade. It’s been re-introduced in every subsequent Congress. But this time around there’s fairly broad bipartisan support. Nevertheless, it faces an uphill battle given the budgetary consequences of reimbursing relatively costly medicines for potentially large numbers of Medicare beneficiaries.

The Treat and Reduce Obesity Act was reintroduced into the 117th Congress by Senators Tom Carper (D-DE) and Bill Cassidy (R-LA) in the Senate and Representatives Ron Kind (D-WI), Tom Reed (R-NY), Raul Ruiz (D-CA) and Brad Wenstrup (R-OH) in the House, respectively. This...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Insurance, Medicare, Patient / Consumer, Pharma, Pharma / Biotech, Provider
What to know about Trump's surgeon general nominee
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Trump's pick for CDC director: 10 things to know
Trump tariffs could drive up generic drug costs: 5 takeaways
Senators urge Congress to avert Medicare physician pay cut

Share This Article